These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37433364)

  • 1. TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation.
    Yin H; Wang Z; Wang D; Nuer M; Han M; Ren P; Ma S; Lin C; Chen J; Xian H; Ai D; Li X; Ma S; Lin Z; Pan Y
    Eur J Pharmacol; 2023 Sep; 955():175883. PubMed ID: 37433364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway.
    Zhang H; Cao Y; Tang J; Wang R
    Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
    Lu GS; Li M; Xu CX; Wang D
    Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.
    Li Y; Huang H; Chen X; Yu N; Ye X; Chen L; Huang Z
    Tissue Cell; 2022 Dec; 79():101918. PubMed ID: 36148733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway.
    Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis.
    Ding K; Jiang X; Wang Z; Zou L; Cui J; Li X; Shu C; Li A; Zhou J
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma.
    Zhou Z; Li Y; Chen S; Xie Z; Du Y; Liu Y; Shi Y; Lin X; Zeng X; Zhao H; Chen G
    Cell Commun Signal; 2024 Jun; 22(1):303. PubMed ID: 38831321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling.
    Zhang Y; Yang W; Han X; Qiao Y; Wang H; Chen T; Li T; Ou WB
    Oncol Res; 2024; 32(6):1119-1128. PubMed ID: 38827327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM12 promotes the resistance of lung adenocarcinoma cells to EGFR-TKI and regulates the immune microenvironment by activating PI3K/Akt/mTOR and RAS signaling pathways.
    Li K; Quan L; Huang F; Li Y; Shen Z
    Int Immunopharmacol; 2023 Sep; 122():110580. PubMed ID: 37418984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1orf74 positively regulates the EGFR/AKT/mTORC1 signaling in lung adenocarcinoma cells.
    Guo J; Li A; Guo R; He Q; Wu Y; Gou Y; Jin J; Huang G
    PeerJ; 2022; 10():e13908. PubMed ID: 36032960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway.
    Xu H; Yang X; Xuan X; Wu D; Zhang J; Xu X; Zhao Y; Ma C; Li D
    Neoplasia; 2021 Jun; 23(6):607-623. PubMed ID: 34102455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
    Zhao W; Xie Y
    Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma.
    Mizutani K; Guo X; Shioya A; Zhang J; Zheng J; Kurose N; Ishibashi H; Motono N; Uramoto H; Yamada S
    Int J Med Sci; 2019; 16(9):1199-1206. PubMed ID: 31588184
    [No Abstract]   [Full Text] [Related]  

  • 17. NOTCH3 Overexpression and Posttranscriptional Regulation by miR-150 Were Associated With EGFR-TKI Resistance in Lung Adenocarcinoma.
    Zhang Y; Chen B; Wang Y; Zhao Q; Wu W; Zhang P; Miao L; Sun S
    Oncol Res; 2019 Jul; 27(7):751-761. PubMed ID: 30732676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CASC5 is a potential tumour driving gene in lung adenocarcinoma.
    Cui Y; Zhang C; Ma S; Guo W; Cao W; Guan F
    Cell Biochem Funct; 2020 Aug; 38(6):733-742. PubMed ID: 32283571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sec61γ is a vital protein in the endoplasmic reticulum membrane promoting tumor metastasis and invasion in lung adenocarcinoma.
    Xu S; Li X; Geng J; Cao Y; Yu Y; Qi L
    Br J Cancer; 2023 Apr; 128(8):1478-1490. PubMed ID: 36759724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells.
    Wu J; Chen Y; Zou H; Xu K; Hou J; Wang M; Tian S; Gao M; Ren Q; Sun C; Lu S; Wang Q; Shu Y; Wang S; Wang X
    Cancer Lett; 2024 Oct; 601():217177. PubMed ID: 39179096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.